Variables | Total (N = 239) | Conventional (N = 198) | HPSD (N = 41) | P value |
---|---|---|---|---|
Age, year | 58.6 ± 9.1 | 58.3 ± 9.3 | 60.3 ± 8.2 | 0.198 |
Male sex | 161 (67.4) | 133 (67.2) | 28 (68.3) | 0.889 |
Height, cm | 166.8 ± 9.0 | 167.0 ± 9.1 | 165.6 ± 8.2 | 0.367 |
Weight, kg | 69.5 ± 10.7 | 69.5 ± 11.0 | 69.4 ± 9.2 | 0.964 |
Body mass index, kg/m2 | 24.9 ± 2.8 | 24.9 ± 2.8 | 25.3 ± 2.9 | 0.337 |
Hypertension | 86 (36.0) | 72 (36.4) | 14 (34.1) | 0.788 |
Diabetes mellitus | 26 (10.9) | 20 (10.1) | 6 (14.6) | 0.410 |
Stroke | 19 (7.9) | 15 (7.6) | 4 (9.8) | 0.750 |
Heart failure | 5 (2.1) | 3 (1.5) | 2 (4.9) | 0.204 |
CHA2DS2-VASc | 1.3 ± 1.1 | 1.3 ± 1.1 | 1.5 ± 1.2 | 0.177 |
Coronary artery disease | 8 (3.3) | 5 (2.5) | 3 (7.3) | 0.141 |
Chronic renal insufficiency | 13 (5.4) | 9 (4.5) | 4 (9.8) | 0.246 |
Anticoagulation with NOAC | 226 (95.0) | 186 (94.4) | 40 (97.6) | 0.697 |
B-type natriuretic peptide, pg/mL | 73.5 ± 71.8 | 71.5 ± 72.1 | 83.3 ± 70.1 | 0.349 |
LA diameter, mm | 39.3 ± 4.9 | 39.2 ± 4.9 | 39.5 ± 4.9 | 0.676 |
LV EF, % | 61.3 ± 5.3 | 61.3 ± 4.8 | 61.0 ± 7.3 | 0.338 |
Cavotricuspid isthmus ablation | 104 (43.5) | 87 (43.9) | 17 (41.5) | 0.771 |